December 13, 2017 2:43 AM ET

Biotechnology

Company Overview of SillaJen Biotherapeutics, Inc.

Key Executives for SillaJen Biotherapeutics, Inc.

NameBoard RelationshipsTitleAge
James M. Burke M.D.No RelationshipsChief Medical Officer--
Helena Chaye Ph.D., LL.B.No RelationshipsChief Business Officer--
Ursula Fritsch Pharm.D.No RelationshipsSenior Vice President57
Georg Roth No RelationshipsChief Technology Officer--
Robin L. Scully No RelationshipsVice President--

SillaJen Biotherapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Herbert Michael Pinedo Ph.D. 43 RelationshipsGilde Healthcare Partners B.V.77
Lawrence N. Shulman M.D., DO 39 RelationshipsHospice Care Network Inc.--
John Crowley Ph.D. 35 RelationshipsCancer Research and Biostatistics--
James Abbruzzese M.D. 27 RelationshipsDuke Cancer Institute--
Kenneth E. Newport C.A., M.Acc., CPA 90 RelationshipsMedGenesis Therapeutix Inc.51
View All Board Members

SillaJen Biotherapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
384.6K
Bonus
235.5K
Total Short Term Compensation
478.7K
Total Value of Options
17.9M
Compensation as of Fiscal Year
SillaJen Biotherapeutics, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Proteostasis Therapeutics, Inc Announces Principal Accounting Officer Changes
December 11, 2017 10:26 PM ET
aTyr Pharma, Inc. Announces Executive Changes
December 11, 2017 10:00 PM ET
Minerva Neurosciences, Inc. Announces Management Changes
December 11, 2017 9:30 PM ET
Flexion Therapeutics, Inc. Announces Chief Medical Officer Changes
December 11, 2017 9:05 PM ET
Alkermes plc Announces Executive Changes, Effective February 1, 2018
December 11, 2017 9:02 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact SillaJen Biotherapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.